Used in the synthesis of modified oligonucleotides for antisense therapy and RNA interference research. The 2’-fluoro modification enhances nuclease resistance and binding affinity to complementary RNA strands, improving stability and efficacy in therapeutic nucleic acid constructs. The DMT (dimethoxytrityl) group enables solid-phase synthesis by protecting the 5’-hydroxyl during chain elongation, while the benzoyl (Bz) group protects the exocyclic amine on the cytosine base. This phosphoramidite building block is essential for producing oligonucleotides with enhanced pharmacokinetic properties used in drug development and molecular diagnostics.